busulfan has been researched along with Alopecia in 15 studies
Alopecia: Absence of hair from areas where it is normally present.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Busulfan chemotherapy, however, is responsible for a permanent alopecia that usually occurs in bone marrow transplant patients." | 7.73 | Permanent alopecia after busulfan chemotherapy. ( Misciali, C; Piraccini, BM; Tosti, A; Vincenzi, C, 2005) |
| "Busulfan-treated patients had an increased risk of veno-occlusive disease (VOD) of the liver (12% v 1%, P =." | 6.69 | Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Nordic Bone Marrow Transplanta ( Jacobsen, N; Lenhoff, S; Ljungman, P; Mellander, L; Nikoskelainen, J; Parkkali, T; Remberger, M; Ringdén, O; Ruutu, T; Sallerfors, B; Vindeløv, L; Volin, L, 1999) |
| " Busulfan chemotherapy, however, is responsible for a permanent alopecia that usually occurs in bone marrow transplant patients." | 3.73 | Permanent alopecia after busulfan chemotherapy. ( Misciali, C; Piraccini, BM; Tosti, A; Vincenzi, C, 2005) |
| "or i." | 2.77 | A prospective multicenter study of treosulfan in elderly patients with recurrent ovarian cancer: results of a planned safety analysis. ( Belau, A; Fuxius, S; Heidrich-Lorsbach, E; Heuser, T; Klare, P; Kölbl, H; Mahner, S; Markmann, S; Oskay-Özcelik, G; Ruhmland, B; Sehouli, J; Sommer, H, 2012) |
| "Busulfan-treated patients had an increased risk of veno-occlusive disease (VOD) of the liver (12% v 1%, P =." | 2.69 | Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Nordic Bone Marrow Transplanta ( Jacobsen, N; Lenhoff, S; Ljungman, P; Mellander, L; Nikoskelainen, J; Parkkali, T; Remberger, M; Ringdén, O; Ruutu, T; Sallerfors, B; Vindeløv, L; Volin, L, 1999) |
| "Alopecia was defined as clinically apparent decreased hair density." | 1.46 | Permanent diffuse alopecia after haematopoietic stem cell transplantation in childhood. ( Ball, LM; Bresters, D; Fiocco, M; Louwerens, M; van Doorn, R; Wanders, DCM, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (20.00) | 18.7374 |
| 1990's | 4 (26.67) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bresters, D | 1 |
| Wanders, DCM | 1 |
| Louwerens, M | 1 |
| Ball, LM | 1 |
| Fiocco, M | 1 |
| van Doorn, R | 1 |
| Champagne, C | 1 |
| Taylor, M | 1 |
| Farrant, P | 1 |
| Palamaras, I | 1 |
| Misciali, C | 3 |
| Vincenzi, C | 3 |
| Robles, WS | 1 |
| Tosti, A | 3 |
| Miteva, M | 1 |
| Fanti, PA | 1 |
| Romanelli, P | 1 |
| Mahner, S | 1 |
| Oskay-Özcelik, G | 1 |
| Heidrich-Lorsbach, E | 1 |
| Fuxius, S | 1 |
| Sommer, H | 1 |
| Klare, P | 1 |
| Belau, A | 1 |
| Ruhmland, B | 1 |
| Heuser, T | 1 |
| Kölbl, H | 1 |
| Markmann, S | 1 |
| Sehouli, J | 1 |
| de OLIVEIRA, H | 1 |
| CRUZ, E | 1 |
| de FONSECA, AS | 1 |
| MEDEIROS, M | 1 |
| CLIFFORD, P | 1 |
| CLIFT, RA | 2 |
| KHAN, AG | 1 |
| TIMMIS, GM | 1 |
| Piraccini, BM | 1 |
| Ljungman, P | 2 |
| Hassan, M | 1 |
| Békássy, AN | 1 |
| Ringdén, O | 3 |
| Oberg, G | 1 |
| Vowels, M | 1 |
| Chan, LL | 1 |
| Giri, N | 1 |
| Russell, S | 1 |
| Lam-Po-Tang, R | 1 |
| Remberger, M | 2 |
| Ruutu, T | 2 |
| Nikoskelainen, J | 1 |
| Volin, L | 1 |
| Vindeløv, L | 1 |
| Parkkali, T | 1 |
| Lenhoff, S | 1 |
| Sallerfors, B | 1 |
| Mellander, L | 1 |
| Jacobsen, N | 1 |
| Tran, D | 1 |
| Sinclair, RD | 1 |
| Schwarer, AP | 1 |
| Chow, CW | 1 |
| Socié, G | 1 |
| Blaise, D | 1 |
| Devergie, A | 1 |
| Martin, PJ | 1 |
| Deeg, HJ | 1 |
| Michallet, M | 1 |
| Sullivan, KM | 1 |
| Chevret, S | 1 |
| Baker, BW | 1 |
| Wilson, CL | 1 |
| Davis, AL | 1 |
| Spearing, RL | 1 |
| Hart, DN | 1 |
| Heaton, DC | 1 |
| Beard, ME | 1 |
| Levantine, A | 1 |
| Almeyda, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Non-Myeloablative Allogeneic Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Chronic Phase CML[NCT00001144] | Phase 2 | 50 participants | Interventional | 1999-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for busulfan and Alopecia
| Article | Year |
|---|---|
Permanent chemotherapy-induced alopecia: a review.
Topics: Adult; Alopecia; Antineoplastic Agents; Busulfan; Female; Humans; Male; Retrospective Studies; Taxoi | 2011 |
Drug reactions. XXIV. Cutaneous reactions to cytostatic agents.
Topics: Alopecia; Aminopterin; Antineoplastic Agents; Asparaginase; Azathioprine; Bleomycin; Busulfan; Chlor | 1974 |
3 trials available for busulfan and Alopecia
10 other studies available for busulfan and Alopecia
| Article | Year |
|---|---|
Permanent diffuse alopecia after haematopoietic stem cell transplantation in childhood.
Topics: Acute Disease; Adolescent; Adult; Alopecia; Busulfan; Child; Child, Preschool; Cross-Sectional Studi | 2017 |
Permanent chemotherapy-induced nonscarring alopecia and premature ovarian failure.
Topics: Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Female; Humans; Primary O | 2015 |
Permanent alopecia after systemic chemotherapy: a clinicopathological study of 10 cases.
Topics: Alopecia; Antineoplastic Agents; Busulfan; Cisplatin; Dermis; Diagnosis, Differential; Docetaxel; Et | 2011 |
Accidental ingestion of a toxic dose of myleran by a child.
Topics: Alopecia; Bone Marrow Diseases; Busulfan; Child; Humans; Mouth | 1963 |
DIMETHYL MYLERAN THERAPY COMBINED WITH ABDOMINAL AORTIC OCCLUSION.
Topics: Adolescent; Alopecia; Aorta; Aorta, Abdominal; Busulfan; Chemotherapy, Cancer, Regional Perfusion; D | 1964 |
Permanent alopecia after busulfan chemotherapy.
Topics: Adult; Alopecia; Antineoplastic Agents, Alkylating; Bone Marrow Transplantation; Busulfan; Female; H | 2005 |
Busulfan concentration in relation to permanent alopecia in recipients of bone marrow transplants.
Topics: Adolescent; Adult; Alopecia; Anemia, Aplastic; Bone Marrow Transplantation; Busulfan; Child; Child, | 1995 |
Factors affecting hair regrowth after bone marrow transplantation.
Topics: Adolescent; Adult; Age Factors; Alopecia; Bone Marrow Purging; Bone Marrow Transplantation; Busulfan | 1993 |
Permanent alopecia following chemotherapy and bone marrow transplantation.
Topics: Adult; Alopecia; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; | 2000 |
Busulphan/cyclophosphamide conditioning for bone marrow transplantation may lead to failure of hair regrowth.
Topics: Adolescent; Adult; Alopecia; Bone Marrow; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; F | 1991 |